Sanctus Thomas de Aquino super quartum libru[m] magistri sententia[rum].

Pie de imp. tomado del colofón en 2K2r

Historia de la portentosa vida y milagros del valenciano... S. Vicente Ferrer : comentada la que escriuio... Fr. Serafin Thomas Miquel...: enmendada en algo la cronologia y añadidas reflexiones al espiritu al fin de los capitulos...

Sign. : a-d4, A-B2, C-Z4, 2A-2Z4, 3A-3X4

Vida, virtudes, milagros, y festivos cultos de Santo Thomas de Villanueva Arzobispo de Valencia, de la Orden de N.G.P. San Agustin

Contiene con portadilla propia : Mich. Io. Bodini Panegyricus Beato Thomae archiep. valent. scriptus ..

Estudio de la utilización de las cenizas de cenicero de centrales termoeléctricas de carbón como adición del cemento portland : análisis comparativo con las cenizas volantes

El empleo de nuevas adiciones en el cemento se plantea como una vía para que éste sea un material más sostenible. En este contexto, las cenizas de fondo o cenicero de las centrales termoeléctricas de carbón actualmente se están llevando a vertederos creando un problema medioambiental o se están empleando con usos minoritarios. Sin embargo, la presente Tesis doctoral demuestra cómo este material puede ser empleado como un componente principal de los cementos portland mezclado en una proporción optimizada con las cenizas volantes o solo. Por tanto, este estudio se puede considerar como un trabajo prenormativo que cubre las demandas de la sociedad tanto económicas como ambientales. Se han estudiado las propiedades químicas, físicas y mecánicas de las cenizas de fondo o cenicero de las centrales termoeléctricas de carbón como una adición potencial de los cementos portland (con adiciones) en comparación con los cementos portland con cenizas volantes. En consecuencia, el objeto de la presente Tesis Doctoral es el análisis de las prestaciones de morteros elaborados con clínkeres de cemento portland y cenizas de fondo o cenicero con cenizas volantes de las centrales termoeléctricas de carbón en unos porcentajes similares a los correspondientes a los CEM II/A-V, CEM II/B-V y CEM IV/A (V) de la UNE-EN 197-1:2011. La caracterización de las cenizas de fondo o cenicero y de las cenizas volantes de las centrales termoeléctricas de carbón se ha realizado mediante las técnicas analíticas de FRX, ICP, análisis químicos, DRX, densidad, granulometría láser, superficie específica Blaine, ATD, TG, puzolanicidad, MEB y EDX; mientras que la caracterización de las mezclas se ha realizado mediante análisis químico (análisis químico, FRX e ICP y), DRX, MIP, granulometría láser, puzolanicidad, MEB y EDX, agua de consistencia normal, inicio y final de fraguado, estabilidad de volumen, colorimetría, calor de hidratación, DTA y TG, asícomo ensayos de resistencia; resistencia a flexión y compresión y ensayos de durabilidad (carbonatación natural, resistencia al hielo-deshielo, resistencia a la acción de los sulfatos y resistencia a la reacción árido-álcali). Finalmente, se han comprobado las propiedades de las cenizas de cenicero y cenizas volantes en hormigones, realizando ensayos de resistencia a compresión y resistividad. Los resultados obtenidos indican que la sustitución parcial o completa de las cenizas volantes por las de cenicero no tiene un efecto tecnológicamente importante en las propiedades ni mecánicas ni durables, incluso los mejora en determinados aspectos. Por tanto, se recomienda la normalización de las cenizas de fondo o cenicero de las centrales termoeléctricas de carbón como componente principal de los cementos portland comunes de la UNE-EN 197-1:2011. Actualmente, la mayoría de las cenizas de fondo se consideran como un residuo que no tiene un posible uso. Sólo se han encontrado algunos datos relativos a la aplicación de este material combinado con cenizas volantes como un componente principal de los cementos portland. Por tanto, la realización de un estudio integrado considerando aspectos que van desde la caracterización de las cenizas hasta las mezclas de conglomerante y la hidratación de éstas, desarrollo de resistencias y demás prestaciones y durabilidad (carbonatación natural, resistencia al hielo-deshielo, resistencia a la acción de los sulfatos y resistencia a la reacción árido-álcali), así como los ensayos de resistencia en hormigón es totalmente novedoso. Como resultado final se propone incorporar estas nuevas adiciones en aplicaciones particulares y en la norma más apropiada para ello. Los resultados han demostrado que la sustitución completa o parcial de las cenizas volantes por cenizas de fondo o cenicero de las centrales termoeléctricas de carbón en cementos de los tipos CEM II/A-V, CEM II/B-V y CEM IV/A no afecta de forma significativa en la resistencia a compresión a 1, 3 ,7, 28 ni 90 días ni a la durabilidad. En parte esto se debe a que la composición química de ambas cenizas es muy similar en la mayoría de los elementos tales como Fe2O3, TiO2, P2O5, SrO2, aunque en algún caso, como en el ZnO, se encuentra alguna ligera diferencia. Por tanto, se pueden esperar unas ligeras diferencias en el mecanismo de hidratación de las diferentes mezclas estudiadas. La presencia de los óxidos mencionados afectará a la composición de la fase acuosa y, en consecuencia, podrían ser elementos lixiviables. Asimismo, influyen de distinta manera en propiedades tales como los tiempos de fraguado y en la durabilidad. New additions to the cement are needed to achieve a more sustainable construction material. Within this context, bottom ashes produced in coal-fired power stations are currently wastes which are dumped provoking an environmental problem. Only in few cases are being used in minor applications. However, the present PhD Thesis shows how this material can be used as a main constituent of Portland cement when it is mixed in an optimised proportion with fly ashes or added to the Portland clinker alone. Therefore, this study may also be considered as a pre-standardization work which covers both the environmental and economic demands of society. Chemical, physical and mechanical characteristics of pulverized coal combustion bottom ash used as a potential constituent of Portland cements (with additions) are studied in comparison to Portland cements with fly ashes. Therefore, the aim of this experimental PhD Thesis is the analysis of the performance of mortars made of clinker of Portland cement and bottom and/or fly ashes in similar proportions to those of CEM II/A-V, CEM II/B-V and CEM IV/A (V) according to EN 197-1:2011. Characterisation of bottom and fly ashes has been done by XRF, ICP, chemical analyses, XRD, density, laser granulometry, Blaine, ATD, TG, pozzolanity, SEM and EDS. Characterisation of bottom and fly ashes mixes has been perform by chemical analyses, XRF, ICP, XRD, MIP, laser granulometry, pozzolanity, SEM, EDS, setting time, soundness, colorimetric test, heat of hydration, ATD, TG, compressive strength, and durability tests (natural carbonation, frost-thaw resistance, sulphate resistance and silica-alkali resistance). In conclusion, it can be established that partial or complete replacement of fly ash by bottom ash has neither significant effect on mechanical nor durability properties. Even, they are improved in several aspects. Therefore, it is recommended to standardise the bottom ash as a main cement constituent of the European standard EN 197-1:2011. Nowadays, most bottom ashes are considered as waste without any potential re-use. Only a few papers deal with the study of this material and its use mixed with fly ashes to be employed as a main constituent of Portland cement. Therefore, the execution of an integrated study considering together aspects from the initial characterization of the ashes and blinder mixes to the hydration steps, strength achievement, leading behaviour and durability (natural carbonation, sulphate attack, aggregate-alcali reaction and freeze-thaw resistance) is totally new. As result, it is proposed to include this new addition for particular applications in the appropriate cement standard. The results have shown that with regard to the compressive strength at 1, 3, 7, 28 and 90 days, partial or complete replacement of fly ash by bottom ash in CEM II/A-V, CEM II/B-V and CEM IV/A has no more significant effects. Partially, this can be explained because the bottom ash contains a similar amount of most of the elements, Fe2O3, TiO2, P2O5, SrO2, and so on, instead of ZnO. Therefore, slight hydration differences are expected. The presence of such oxides might have a significant effect on pore solution concentration and so will be leachable constituents. They will also play an important role in the cement properties such as setting times and durability.

Por D. Thomas Galiano Enriquez... vezino de la ciudad de Murcia... en el pleyto con Don Thomas Galiano Espuche... D. Juan Galiano... y D. Thomas Galiano... sobre la succesion del Vinculo que dexò fundado D. Francisco Galiano... [Texto impreso]

Sign. : []2, B-E2, F1

Divus Thomas cum patribus ex prophetis locutus... sive Dissertationes theologicae scholastico-dogmaticae et mystico-doctrinales ... Divi Thomae ... [Texto impreso]

Sign.: [calderon]-3[calderon]4, A-Z4, Aa-Zz4, Aaa-Xxx4

α1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: Application as an antipathogenic agent

The important role of furin in the proteolytic activation of many pathogenic molecules has made this endoprotease a target for the development of potent and selective antiproteolytic agents. Here, we demonstrate the utility of the protein-based inhibitor α1-antitrypsin Portland (α1-PDX) as an antipathogenic agent that can be used prophylactically to block furin-dependent cell killing by Pseudomonas exotoxin A. Biochemical analysis of the specificity of a bacterially expressed His- and FLAG-tagged α1-PDX (α1-PDX/hf) revealed the selectivity of the α1-PDX/hf reactive site loop for furin (Ki, 600 pM) but not for other proprotein convertase family members or other unrelated endoproteases. Kinetic studies show that α1-PDX/hf inhibits furin by a slow tight-binding mechanism characteristic of serpin molecules and functions as a suicide substrate inhibitor. Once bound to furin’s active site, α1-PDX/hf partitions with equal probability to undergo proteolysis by furin at the C-terminal side of the reactive center -Arg355-Ile-Pro-Arg358-↓ or to form a kinetically trapped SDS-stable complex with the enzyme. This partitioning between the complex-forming and proteolytic pathways contributes to the ability of α1-PDX/hf to differentially inhibit members of the proprotein convertase family. Finally, we propose a structural model of the α1-PDX-reactive site loop that explains the high degree of enzyme selectivity of this serpin and which can be used to generate small molecule furin inhibitors.

NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α

Several angiogenic factors and extracellular matrix-degrading enzymes that promote invasion and metastasis of cancer are produced by stromal fibroblasts that surround cancer cells. The expression of genes that code for some of these proteins is regulated by the transcription factor NF-κB. In this report, we demonstrate that conditioned medium (CM) from estrogen receptor (ER)-negative but not ER-positive breast cancer cells induces NF-κB in fibroblasts. In contrast, CM from both ER-positive and ER-negative breast cancer cells induces NF-κB in macrophages and endothelial cells. NF-κB activation in fibroblasts was accompanied by induction of interleukin 6 (IL-6) and urokinase plasminogen activator (uPA), both of which promote angiogenesis and metastasis. A survey of cytokines known for their ability to induce NF-κB identified IL-1α as the factor responsible for NF-κB activation in fibroblasts. Analysis of primary breast carcinomas revealed the presence of IL-1α transcripts in majority of lymph node-positive breast cancers. These results along with the known role of IL-1α and IL-6 in osteoclast formation provide insight into the mechanism of metastasis and hypercalcemia in advanced breast cancers.

A novel amplicon at 8p22–23 results in overexpression of cathepsin B in esophageal adenocarcinoma

Cathepsin B (CTSB) is overexpressed in tumors of the lung, prostate, colon, breast, and stomach. However, evidence of primary genomic alterations in the CTSB gene during tumor initiation or progression has been lacking. We have found a novel amplicon at 8p22–23 that results in CTSB overexpression in esophageal adenocarcinoma. Amplified genomic NotI–HinfI fragments were identified by two-dimensional DNA electrophoresis. Two amplified fragments (D4 and D5) were cloned and yielded unique sequences. Using bacterial artificial chromosome clones containing either D4 or D5, fluorescent in situ hybridization defined a single region of amplification involving chromosome bands 8p22–23. We investigated the candidate cancer-related gene CTSB, and potential coamplified genes from this region including farnesyl-diphosphate farnesyltransferase (FDFT1), arylamine N-acetyltransferase (NAT-1), lipoprotein lipase (LPL), and an uncharacterized expressed sequence tag (D8S503). Southern blot analysis of 66 esophageal adenocarcinomas demonstrated only CTSB and FDFT1 were consistently amplified in eight (12.1%) of the tumors. Neither NAT-1 nor LPL were amplified. Northern blot analysis showed overexpression of CTSB and FDFT1 mRNA in all six of the amplified esophageal adenocarcinomas analyzed. CTSB mRNA overexpression also was present in two of six nonamplified tumors analyzed. However, FDFT1 mRNA overexpression without amplification was not observed. Western blot analysis confirmed CTSB protein overexpression in tumor specimens with CTSB mRNA overexpression compared with either normal controls or tumors without mRNA overexpression. Abundant extracellular expression of CTSB protein was found in 29 of 40 (72.5%) of esophageal adenocarcinoma specimens by using immunohistochemical analysis. The finding of an amplicon at 8p22–23 resulting in CTSB gene amplification and overexpression supports an important role for CTSB in esophageal adenocarcinoma and possibly in other tumors.

CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling

B cell development and humoral immune responses are controlled by signaling thresholds established through the B lymphocyte antigen receptor (BCR) complex. BCR signaling thresholds are differentially regulated by the CD22 and CD19 cell surface receptors in vivo. B cells from CD22-deficient mice exhibit characteristics of chronic stimulation and are hyper-responsive to BCR crosslinking with augmented intracellular Ca2+ responses. By contrast, B cells from CD19-deficient mice are hypo-responsive to transmembrane signals. To identify signaling molecules involved in the positive and negative regulation of signaling thresholds, the signal transduction pathways activated after BCR crosslinking were examined in CD22- and CD19-deficient B cells. These comparisons revealed that tyrosine phosphorylation of Vav protein was uniquely augmented after BCR or CD19 crosslinking in CD22-deficient B cells, yet was modest and transient after BCR crosslinking in CD19-deficient B cells. Ligation of CD19 and CD22 in vivo is likely to positively and negatively regulate BCR signaling, respectively, because CD19 crosslinking was more efficient than BCR crosslinking at inducing Vav phosphorylation. However, simultaneous crosslinking of CD19 with the BCR resulted in a substantial decrease in Vav phosphorylation when CD22 was expressed. Thus, the differential regulation of Vav tyrosine phosphorylation by CD19 and CD22 may provide a molecular mechanism for adjusting BCR signaling thresholds.

Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin

Ultraviolet-B (UVB) (290–320 nm) radiation-induced cyclobutane pyrimidine dimers within the DNA of epidermal cells are detrimental to human health by causing mutations and immunosuppressive effects that presumably contribute to photocarcinogenesis. Conventional photoprotection by sunscreens is exclusively prophylactic in nature and of no value once DNA damage has occurred. In this paper, we have therefore assessed whether it is possible to repair UVB radiation-induced DNA damage through topical application of the DNA-repair enzyme photolyase, derived from Anacystis nidulans, that specifically converts cyclobutane dimers into their original DNA structure after exposure to photoreactivating light. When a dose of UVB radiation sufficient to induce erythema was administered to the skin of healthy subjects, significant numbers of dimers were formed within epidermal cells. Topical application of photolyase-containing liposomes to UVB-irradiated skin and subsequent exposure to photoreactivating light decreased the number of UVB radiation-induced dimers by 40–45%. No reduction was observed if the liposomes were not filled with photolyase or if photoreactivating exposure preceded the application of filled liposomes. The UVB dose administered resulted in suppression of intercellular adhesion molecule-1 (ICAM-1), a molecule required for immunity and inflammatory events in the epidermis. In addition, in subjects hypersensitive to nickel sulfate, elicitation of the hypersensitivity reaction in irradiated skin areas was prevented. Photolyase-induced dimer repair completely prevented these UVB radiation-induced immunosuppressive effects as well as erythema and sunburn-cell formation. These studies demonstrate that topical application of photolyase is effective in dimer reversal and thereby leads to immunoprotection.

Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor

The assembly of a pre-B cell receptor (pre-BCR) composed of an Ig μ heavy chain (μH-chain), the surrogate light (SL) chain, and the Igα/β dimer is critical for late pro-B cells to advance to the pre-B cell stage. By using a transgenic mouse model, in which μH-chain synthesis is solely driven by a tetracycline-controlled transactivator, we show that de novo synthesis of μH-chain in transgenic pro-B cells not only induces differentiation but also proliferation. This positive effect of μH-chain synthesis on proliferation requires the presence of SL chain and costimulatory signals provided by stromal cells or IL-7. We conclude that pre-BCR signaling induces clonal expansion of early pre-B cells.

B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice

Prion replication in spleen and neuroinvasion after i.p. inoculation of mice is impaired in forms of immunodeficiency where mature B lymphocytes are lacking. In spleens of wild-type mice, infectivity is associated with B and T lymphocytes and stroma but not with circulating lymphocytes. We generated transgenic prion protein knockout mice overexpressing prion protein in B lymphocytes and found that they failed to accumulate prions in spleen after i.p. inoculation. We conclude that splenic B lymphocytes are not prion-replication competent and that they acquire prions from other cells, most likely follicular dendritic cells with which they closely associate and whose maturation depends on them.

Phytochrome B Affects the Levels of a Graft-Transmissible Signal Involved in Tuberization1

Grafting experiments between phytochrome B antisense and wild-type potato (Solanum tuberosum L. subsp. andigena [line 7540]) plants provide evidence that phytochrome B is involved in the production of a graft-transmissible inhibitor of tuberization, the level of which is reduced in the antisense plants, allowing them to tuberize in noninducing photoperiods.

Viral dynamics in hepatitis B virus infection.

Treatment of chronic hepatitis B virus (HBV) infections with the reverse transcriptase inhibitor lamivudine leads to a rapid decline in plasma viremia and provides estimates for crucial kinetic constants of HBV replication. We find that in persistently infected patients, HBV particles are cleared from the plasma with a half-life of approximately 1.0 day, which implies a 50% daily turnover of the free virus population. Total viral release into the periphery is approximately 10(11) virus particles per day. Although we have no direct measurement of the infected cell mass, we can estimate the turnover rate of these cells in two ways: (i) by comparing the rate of viral production before and after therapy or (ii) from the decline of hepatitis B antigen during treatment. These two independent methods give equivalent results: we find a wide distribution of half-lives for virus-producing cells, ranging from 10 to 100 days in different patients, which may reflect differences in rates of lysis of infected cells by immune responses. Our analysis provides a quantitative understanding of HBV replication dynamics in vivo and has implications for the optimal timing of drug treatment and immunotherapy in chronic HBV infection. This study also represents a comparison for recent findings on the dynamics of human immunodeficiency virus (HIV) infection. The total daily production of plasma virus is, on average, higher in chronic HBV carriers than in HIV-infected patients, but the half-life of virus-producing cells is much shorter in HIV. Most strikingly, there is no indication of drug resistance in HBV-infected patients treated for up to 24 weeks.